EB-002

EB-002
Clinical data
Other namesEB002; EB-373; EB373; Synthetic psilocin prodrug
Routes of
administration		Oral[1]
Drug classNon-selective serotonin receptor agonist; Serotonin 5-HT2A receptor agonist; Serotonergic psychedelic; Hallucinogen

EB-002, also formerly known as EB-373, is a synthetic prodrug of the non-selective serotonin receptor agonist and serotonergic psychedelic psilocin which is under development for the treatment of neuropsychiatric disorders like depression and anxiety disorders.[1][2][3][4][5] It is taken orally.[1] The drug is under development by Enveric Biosciences.[1][2][3][5] As of November 2024, it is in the preclinical research stage of development.[1][2] In November 2024, Enveric Biosciences out-licensed EB-002 to MycoMedica Life Sciences in a deal that was estimated to be worth as much as $62 million.[3] Its exact chemical structure does not yet appear to have been disclosed.[1]

See also

References

  1. ^ a b c d e f "Enveric Biosciences". AdisInsight. 22 November 2024. Retrieved 16 February 2025.
  2. ^ a b c "Delving into the Latest Updates on EB-373 with Synapse". Synapse. 25 January 2025. Retrieved 16 February 2025.
  3. ^ a b c Jackson A (12 November 2024). "Enveric inks $62M licensing deal for psilocin prodrug". Green Market Report. Retrieved 16 February 2025.
  4. ^ "Investigational Psilocin Prodrug Gains Patent Protection for Sleep Disorder Applications". Sleep Review. 18 July 2024. Retrieved 16 February 2025.
  5. ^ a b Carreon M (30 July 2024). "Another Psychedelic Drug Derivative Secures Patent and Awaits FDA Approval". DoubleBlind Mag. Retrieved 15 March 2025.
Stub icon

This hallucinogen-related article is a stub. You can help Wikipedia by adding missing information.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.